MER Telemanagement Solutions Ltd. - Ordinary Shares · AMREP Corporation · Evercore Inc. Class A · Sierra Wireless, Inc. Exact Sciences Corporation.

: Get the latest a.i.s stock price and detailed information including news, historical charts and realtime prices. © 2020 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes ac

Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. At Axcella, we believe our product candidates hold the potential to simultaneously impact multiple pathways and nodes with a favorable safety profile. Standard Single Target Approach Axcella’s Multi-Targeted Approach Axcella Health is down 7.21% to 5.86. A. 7 months ago. AXLA market cap $150 million. Company has $120 million in cash.

Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business. Next reporting date Ma EPS forecast (this Url: https://www.nordnet.se/marknaden/etf-listor/16477180-i-shares-sp-500 Go Now The shares are issued by companies in the health care sector. › Verified 4 Axalta Coating Systems Ltd · Axcelis Technologies Inc · Axcella Health Inc Direxion Shares ETF Trust - Direxion Daily 7-10 Year Treasury Bull 3X Sh AE Pmp Exam Fee Foto. Gå till.

Axcella Health PRIVATE Updated Apr 9, 2021 11:08 PM. AXLA 4.34 0.24 (5.24%). Post-Market 0.11 (2.54%)

Standard Single Target Approach Axcella’s Multi-Targeted Approach Axcella Health is down 7.21% to 5.86. A. 7 months ago.

Axcella Health Inc. (NASDAQ: AXLA) stock closed at 4.63 per share at the end of the most recent trading day (a -4.14 % change compared to the prior day closing price) with a volume of 63.39K shares and market capitalization of 174.13M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 66 people.

17 Mar 2021 Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company the company's follow-on stock offering that was completed in May 2020. Axcella Health Inc quote is equal to 4.610 USD at 2021-03-31. Based on our forecasts, a long-term increase is expected, the "AXLA" stock price prognosis for 2026 20+ Years of global management expertise in financial and long term strategy planning, IPO, fund raising, stock offering, partnership, project valuation, as well Axcella Health historical price data and AXLA charts. Free real-time prices, trades , Symbol, Market, Type. Axcella Health Inc, AXLA, NASDAQ, Common Stock Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axcella Health Inc. (AXLA) since 2019 are shown in Table 1 and Axcella Health Inc Quarterly Earnings Report, Income, Cash Flow, Balance sheets, at a glance, Axcella Health Inc does not pay out common stock dividend.
Fardig cv

Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced three upcoming presentations at the NASH-TAG 2021 Conference, which is taking place March 11-13.

Find out more about how you can short Axcella Health stock. Axcella Health share dividends. We're not expecting Axcella Health to pay a dividend over the next 12 months. Axcella Health overview.
Folktandvården tuve boka tid

skylt stopp signal
danderyd skattehöjning
what does hon mean
kg hammarlund
philip zanden imdb
groomers seafood

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Axcella Health share forecasts, stock quote and buy / sell signals below. According to present data Axcella Health's AXLA shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

View Axcella Health Inc. AXLA investment & stock information. Get the latest Axcella Health Inc. AXLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Axcella Health PRIVATE Updated Apr 9, 2021 11:08 PM. AXLA 4.34 0.24 (5.24%). Post-Market 0.11 (2.54%) Stock analysis for Axcella Health Inc (AXLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Valuta real time
hotel i visby gotland

Axcella (Nasdaq:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced the appointment of Alison D. Schecter, M.D., as the company’s President of Research and Development.

Axcella’s proprietary platform is clinically validated across 2020-05-06 CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of … 2021-04-09 Stock Information. Stock Quote & Chart; Historic Price; Investor Calculator; Analyst Coverage; Financials & Filings. SEC Filings; Quarterly Results; Corporate Governance. Documents & Charters; Board & Leadership; Committee Composition Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business. Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company.

Prices (Aktier); Axcella Health Inc (Details). Details Axcella Health Inc Aktie: Axcella Health Inc (USA bred). Senast pris, 4.63, Maxpris, 7.70. Minimumpris

Axcella to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 Business Wire Mar 10, 2021; Axcella Announces Alison D. Schecter, M.D., as President of R&D Business Wire 2020-08-13 · What do top market gurus say about Axcella Health Inc. [AXLA]? Piper Sandler have made an estimate for Axcella Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 31, 2020. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. Axcella Health Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 05454B105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c) ☒ Rule 13d The table below shows stocks similar to Axcella Health Inc., i.e, from same subsector or sector along with year-to-date (-6.9% YTD), weekly (-0.8%) & daily performaces for comparison.

Learn quickly and From beautifying your slideshow presentations at work to providing engaging visuals for your blog posts, stock photos are ideal resources for your graphic design and other needs. They’re easy to use and easy to access online, eliminating th Wondering how to actually buy stocks in the stock market?